Clinical Trial: An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patient
Brief Summary: The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Plasma LDL-C.
Original Primary Outcome:
Current Secondary Outcome: Plasma TG and HDL-C; proportion of patients achieving LDL-C targets; tolerability.
Original Secondary Outcome:
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: September 23, 2004
Date Started: January 2003
Date Completion:
Last Updated: March 9, 2017
Last Verified: March 2017